Does Rallies show Form 4 insider transactions for SRTA?

Yes. Rallies tracks SRTA insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is SRTA research on Rallies investment advice?

No. Rallies provides research, data, and educational context for SRTA. It does not provide personalized investment advice.

SRTA (Strata Critical Medical, Inc. Class A Common Stock) Stock Analysis - Insider Trades

Strata Critical Medical, Inc. Class A Common Stock (SRTA) is a publicly traded the market company. As of May 21, 2026, SRTA trades at $5.41 with a market cap of $464.65M and a P/E ratio of 11.01. SRTA moved +6.13% today. Year to date, SRTA is -1.77%; over the trailing twelve months it is flat. Its 52-week range spans $3.85 to $6.02. Analyst consensus is strong buy with an average price target of $9.17. Rallies surfaces SRTA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading SRTA stock inside the company?

Recent SRTA insider activity includes Heyburn William A. bought 17.00K, LAUCK ANDREW bought 5.00K, Love Reginald sold 11.00K, and Love Reginald sold 11.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

SRTA Key Metrics

Key financial metrics for SRTA
Metric	Value
Price	$5.41
Market Cap	$464.65M
P/E Ratio	11.01
EPS	$0.50
Dividend Yield	0.00%
52-Week High	$6.02
52-Week Low	$3.85
Volume	737.16K
Avg Volume	0
Revenue (TTM)	$197.14M
Net Income	$41.35M
Gross Margin	20.86%

Recent SRTA Insider Trades

Heyburn William A. bought 17.00K (~$76.04K) on Dec 9, 2025.
LAUCK ANDREW bought 5.00K (~$21.82K) on Dec 5, 2025.
Love Reginald sold 11.00K (~$48.07K) on Nov 20, 2025.
Love Reginald sold 11.00K (~$47.43K) on Nov 19, 2025.

Latest SRTA News

Strata Critical Medical’s Public and Private Warrants Expire at 5 PM ET — May 7, 2026
Strata Critical Medical Sees 87.4% Q1 Revenue Surge to $67.4M — May 6, 2026
Strata Critical Medical Acquires Ohio Valley Perfusion for $1M, Adds 8 Clinicians — Apr 30, 2026
Strata Critical Medical Sees 83.5% Q4 Revenue Growth, Raises 2026 Guidance to $260M–$275M — Mar 3, 2026

SRTA Analyst Consensus

4 analysts cover SRTA: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $9.17.

Common questions about SRTA

Who is trading SRTA stock inside the company?: Recent SRTA insider activity includes Heyburn William A. bought 17.00K, LAUCK ANDREW bought 5.00K, Love Reginald sold 11.00K, and Love Reginald sold 11.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for SRTA?: Yes. Rallies tracks SRTA insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is SRTA research on Rallies investment advice?: No. Rallies provides research, data, and educational context for SRTA. It does not provide personalized investment advice.